NCT05560308 2022-10-03
Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy
Tianjin Medical University Cancer Institute and Hospital
Phase NA Unknown
Clinical Trials
1 trialsOTHER × Interventional × HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy × Clear all